<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

30/04/2024 20:30
30/04/2024 17:45
30/04/2024 20:36
30/04/2024 14:18
30/04/2024 17:21
30/04/2024 10:37
30/04/2024 20:44
30/04/2024 10:52
30/04/2024 16:03
30/04/2024 16:01
30/04/2024 19:20
30/04/2024 20:22
30/04/2024 09:09
30/04/2024 16:44
30/04/2024 20:22
30/04/2024 19:33
30/04/2024 14:58
30/04/2024 04:11
30/04/2024 16:00
30/04/2024 13:26
30/04/2024 11:42
29/04/2024 15:51
30/04/2024 17:33
30/04/2024 10:28
30/04/2024 16:48
30/04/2024 12:52
30/04/2024 21:09
30/04/2024 19:35
30/04/2024 19:39
30/04/2024 15:14
30/04/2024 17:42
30/04/2024 11:43
29/04/2024 12:00
29/04/2024 19:33
30/04/2024 16:41
30/04/2024 06:56
30/04/2024 12:32
30/04/2024 14:21